Contractor
MRIGLOBAL
- UEI
- HKQHNFKNKL15
- Parent UEI
- GW42LHLDZ418
- Resolved by
- uei
- Confidence
- 1.000
Active from Dec 29, 2016 to Sep 22, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N91019F00129 CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT | Department of Health and Human Services | MO | Jun 17, 2019 | $17,051,878 |
| 75N91026F00001 MANUFACTURE OF CLINICAL-GRADE LFA-9 | Department of Health and Human Services | MO | Sep 21, 2026 | $337,762 |
| 70RWMD23C00000023 MRIGLOBAL COST PLUS FIXED FEE DHS CWMD OBAA TOPIC SOLICITATION 15 AWARD FOR AGNOSTIC THREAT DETECTION SYSTEM (ATDS) PROPOSAL FOR RESEARCH AND DEVELOPMENT SERVICES | Department of Homeland Security | MO | Sep 27, 2023 | $5,372,443 |
| HHSN272201700001C IGF::OT::IGF MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA) | Department of Health and Human Services | MD | Dec 29, 2016 | $8,779,591 |
| 75A50226C00001 PORTABLE BIOCONTAINMENT UNITS (PBCUS) - EBOLA RESPONSE 2026 | Department of Health and Human Services | MD | Jun 26, 2026 | $699,683 |
| 75N93026F00002 DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM | Department of Health and Human Services | MO | Feb 27, 2026 | $787,684 |
| 70US0926F3OTH3091 BIOLOGICAL COUNTERMEASURES BPA CALL ORDER #3 - T&E SERVICES | Department of Homeland Security | DC | Aug 31, 2026 | $240,343 |
| 75N98026F00001 THIS TASK ORDER IS TO PROVIDE REGULATORY SUPPORT FOR VAGINITIS PCR ASSAY. | Department of Health and Human Services | MO | Aug 24, 2026 | $369,210 |
| 75N98026F00002 NINDS' DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP): SHAMLOO-SELECTIVE CB2 AGONIST; MRI RESEARCH INC:1186811 [26-000042] | Department of Health and Human Services | MO | Aug 12, 2026 | $1,363,408 |
| 75N93026F00003 PERFORMING FDA 510K ENABLING STUDIES FOR A DIAGNOSTIC TO DETECT CIPROFLOXICIN RESISTANCE OR SUSCEPTABILITY | Department of Health and Human Services | MO | May 11, 2026 | $1,571,051 |
| 75N98026D00014 NINDS DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) | Department of Health and Human Services | — | May 4, 2026 | — |
| 75N93021D00041 COMPREHENSIVE AND RAPID RESPONSE TO NIAID RESEARCH PROGRAMS | Department of Health and Human Services | — | Aug 31, 2021 | — |
| 75N91023D00010 IDIQ CONTRACT FOR CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT SERVICES | Department of Health and Human Services | — | Jun 29, 2023 | — |
| 68HERH25C0005 PORTABLE HIGH THROUGHPUT INTEGRATED LABORATORY IDENTIFICATION SYSTEMS (PHILIS) PLATFORM MODERNIZATION 2.0 | Environmental Protection Agency | NJ | Jan 22, 2025 | $13,813,179 |
| 75N93022D00002 EO14398 THE CONTRACTOR SHALL PROVIDE NIAID WITH A BROAD AND FLEXIBLE RANGE OF CAPABILITIES THAT ARE REQUIRED FOR PRECLINICAL AND TRANSLATIONAL DEVELOPMENT SUPPORT FOR PROMISING VACCINES AND RELATED PRODUCTS FOR HIV AND OTHER CANDIDATE AGENTS. | Department of Health and Human Services | — | Jul 23, 2026 | — |
| 75N93026F00001 REGULATORY SUPPORT FOR SOFTWARE AS MEDICAL DEVICE (SAMD) FOR NEXT-GEN SEQUENCING ID ANALYSIS | Department of Health and Human Services | MO | Mar 27, 2026 | $7,192 |
| 140D0425P0205 PER E.O 14398, THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO INCORPORATE FAR CLAUSE 52.222-90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (DEVIATION APRIL 2026). | Department of the Interior | MD | Jul 20, 2026 | $739,894 |
| 75N93024C00002 EO 14398; MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA) | Department of Health and Human Services | MD | Jul 20, 2026 | $5,169,142 |
| 75N91023D00007 EO 14398 ANALYSIS AND SYNTHESIS OF GMP AND NON-GMP BULK DRUGS AND PHARMACEUTICAL FORMULATIONS | Department of Health and Human Services | — | Jul 20, 2026 | — |
| 75N98026D00031 ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. SINGLE AWARD R&D IDIQ CONTRACT. JULY 20, 2026 - JULY 19, 2031. DAP-NCAP-00000009 | Department of Health and Human Services | — | Jul 17, 2026 | — |
| 75A50123F61001 BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | Department of Health and Human Services | MO | Jul 17, 2026 | $149,664 |
| 75N98026F00002 PHASE 1 SINGLE ASCENDING DOSE PHARMACOKINETICS STUDY: PARENT/METABOLITE(S). ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. JULY 20, 2026 - JANUARY 19, 2028. TASK ORDER 02. DAP-NCAP-00000009 | Department of Health and Human Services | MO | Jul 17, 2026 | $478,052 |
| 75N98026F00001 PHASE 1 SINGLE ASCENDING DOSE PHARMACOKINETICS STUDY. ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. JULY 20, 2026 - JANUARY 19, 2028. TASK ORDER 01. DAP-NCAP-00000009 | Department of Health and Human Services | MO | Jul 17, 2026 | $382,839 |
| 75N95024D00012 EO 14398 IDIQ: CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG SUBSTANCES | Department of Health and Human Services | — | Jul 15, 2026 | — |
| 47QRCA25DU229 ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC) | General Services Administration | — | Dec 17, 2024 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier HKQHNFKNKL15, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 24, 2026.